Efficacy of Bumetanide in Children With Autism Spectrum Disorder Guided by Peripheral Blood Biomarkers and Machine Learning Models

Clinical trial NCT07005414 · COMPLETED

Trial details

NCT number: NCT07005414
Sponsor: Fei Li
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Autism Spectrum Disorder

Start date: 2025-06-04
Primary completion: 2026-04-21
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.